Search Results - Novartis,

Novartis: The Challenge of Success (A)

Authors: Sandra J. Sucher Stacy McManus

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

Novartis' Sandoz: Between Generics and Pharma

Authors: Carin-Isabel Knoop Krishna G. Palepu

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

MarketLine Company Profile: Novartis AG.

Source: Novartis AG MarketLine Company Profile. 3/23/2026, p1-76. 76p.

The origins of Novo Nordisk and Novartis products: piloting a framework to identify the public contributions.

Authors: Fabian, Daniel Sehic, Ozren Wild, Claudia

Source: Journal of Pharmaceutical Policy & Practice. Dec2025, Vol. 18 Issue 1, p1-21. 21p.

Novartis Pharma: The Business Unit Model

Authors: Carin-Isabel Knoop Cate Reavis Srikant M. Datar

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

Novartis Profit, Sales Decline as Generic Competition Bites.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 4/28/2026, pN.PAG-N.PAG. 1p.

Novartis to Exit Indian Unit With $159 Million Stake Sale.

Authors: Sharma, Akriti (AUTHOR)

Source: Bloomberg.com. 2/20/2026, pN.PAG-N.PAG. 1p.

Novartis to Exit Listed Indian Unit With $159 Million Stake Sale.

Authors: Sharma, Akriti (AUTHOR)

Source: Bloomberg.com. 2/19/2026, pN.PAG-N.PAG. 1p.

Novartis (A): Being a Global Leader

Authors: Carin-Isabel Knoop Srikant M. Datar

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

Novartis AG SWOT Analysis.

Source: Novartis AG SWOT Analysis. 3/31/2026, p1-7. 7p.

Novartis to Buy Breast Cancer Drug for as Much as $3 Billion.

Authors: Sundaram, Karthikeyan (AUTHOR)

Source: Bloomberg.com. 3/20/2026, pN.PAG-N.PAG. 1p.

Novartis to Buy Excellergy in Deal Worth Up to $2 Billion.

Source: Bloomberg.com. 3/27/2026, pN.PAG-N.PAG. 1p.

Trump Says Tariffs Pushed Novartis to Expand Operations in US.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 2/20/2026, pN.PAG-N.PAG. 1p.

Novartis Sees Profit Declining This Year as Generics Bite.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 2/4/2026, pN.PAG-N.PAG. 1p.

Novartis Raises Peak Sales Targets for Key Cancer Drugs.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 11/20/2025, pN.PAG-N.PAG. 1p.

Novartis to Acquire Excellergy in Deal Worth Up to $2 Billion.

Source: Bloomberg.com. 3/27/2026, pN.PAG-N.PAG. 1p.

Novartis to Acquire Breast Cancer Drug in Up to $3 Billion Deal.

Authors: Sundaram, Karthikeyan (AUTHOR)

Source: Bloomberg.com. 3/20/2026, pN.PAG-N.PAG. 1p.

Novartis Agrees to Buy Avidity in $12 Billion Biotech Deal.

Authors: Davis, Michelle F. Hipwell, Deirdre

Source: Bloomberg.com. 10/26/2025, pN.PAG-N.PAG. 1p.

The Novartis Malaria Initiative

Authors: Emilie Billaud Michael Chu Vincent Dessain

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

Novartis Gets Boost as Autoimmune Drug Suceeds in Key Trials.

Authors: Petroff, Katerina (AUTHOR)

Source: Bloomberg.com. 8/11/2025, pN.PAG-N.PAG. 1p.